SYRE
Price
$23.89
Change
+$0.76 (+3.29%)
Updated
Dec 20, 04:59 PM (EDT)
66 days until earnings call
TCRX
Price
$2.96
Change
+$0.03 (+1.02%)
Updated
Dec 20, 04:59 PM (EDT)
72 days until earnings call
Ad is loading...

SYRE vs TCRX

Header iconSYRE vs TCRX Comparison
Open Charts SYRE vs TCRXBanner chart's image
Spyre Therapeutics
Price$23.89
Change+$0.76 (+3.29%)
Volume$18.59K
CapitalizationN/A
TScan Therapeutics
Price$2.96
Change+$0.03 (+1.02%)
Volume$4.2K
CapitalizationN/A
SYRE vs TCRX Comparison Chart
Loading...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SYRE vs. TCRX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SYRE is a Hold and TCRX is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (SYRE: $23.86 vs. TCRX: $2.97)
Brand notoriety: SYRE and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SYRE: 216% vs. TCRX: 254%
Market capitalization -- SYRE: $1.4B vs. TCRX: $157.71M
SYRE [@Biotechnology] is valued at $1.4B. TCRX’s [@Biotechnology] market capitalization is $157.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SYRE’s FA Score shows that 0 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • SYRE’s FA Score: 0 green, 5 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, TCRX is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SYRE’s TA Score shows that 4 TA indicator(s) are bullish while TCRX’s TA Score has 4 bullish TA indicator(s).

  • SYRE’s TA Score: 4 bullish, 6 bearish.
  • TCRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TCRX is a better buy in the short-term than SYRE.

Price Growth

SYRE (@Biotechnology) experienced а -1.08% price change this week, while TCRX (@Biotechnology) price change was +4.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

SYRE is expected to report earnings on Feb 27, 2025.

TCRX is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($1.4B) has a higher market cap than TCRX($158M). SYRE YTD gains are higher at: 10.874 vs. TCRX (-49.057). TCRX has higher annual earnings (EBITDA): -102.91M vs. SYRE (-195.07M). SYRE has more cash in the bank: 414M vs. TCRX (271M). SYRE has less debt than TCRX: SYRE (0) vs TCRX (90.4M). TCRX has higher revenues than SYRE: TCRX (9.36M) vs SYRE (0).
SYRETCRXSYRE / TCRX
Capitalization1.4B158M887%
EBITDA-195.07M-102.91M190%
Gain YTD10.874-49.057-22%
P/E Ratio1.72N/A-
Revenue09.36M-
Total Cash414M271M153%
Total Debt090.4M-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SYRETCRX
RSI
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
85%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Ad is loading...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VAFNX31.820.40
+1.27%
Invesco American Franchise R5
FMFAX91.321.01
+1.12%
Fidelity Advisor Materials A
WGFIX10.870.05
+0.46%
William Blair Global Leaders I
EDIAX10.480.04
+0.38%
Eaton Vance Global Income Builder A
ARTGX21.970.08
+0.37%
Artisan Global Value Investor

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with SNPX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
+3.16%
SNPX - SYRE
47%
Loosely correlated
+19.69%
PMN - SYRE
44%
Loosely correlated
+1.88%
APGE - SYRE
44%
Loosely correlated
+1.47%
TCRX - SYRE
44%
Loosely correlated
+1.37%
ABSI - SYRE
40%
Loosely correlated
+2.40%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with VIR. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
+1.37%
VIR - TCRX
42%
Loosely correlated
-0.41%
PRME - TCRX
40%
Loosely correlated
+3.94%
CRVO - TCRX
39%
Loosely correlated
N/A
FATE - TCRX
39%
Loosely correlated
+1.20%
IMNM - TCRX
39%
Loosely correlated
-0.99%
More